Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11672874 Methods and compositions for genomic integration

Overview Structured Data Issues Contributors Activity

Is a

0

Current Assignee

Myeloid Therapeutics

0

Date Filed

October 12, 2021

0

Date of Patent

June 13, 2023

0

Patent Applicant

Myeloid Therapeutics

0

Patent Application Number

17499232

0

Patent Citations

US Patent 9353370 Functional nucleic acid molecule and use thereof

0

US Patent 9481892 Controlled activation of non-LTR retrotransposons in mammals

0

US Patent 9518116 Therapeutic CD47 antibodies

0

US Patent 8198020 Compositions and methods for enhancing phagocytosis or phagocyte activity

0

US Patent 8709412 Modulation of TIM receptor activity in combination with cytoreductive therapy

0

US Patent 9149519 Chimeric human immunodeficiency virus type 1 (HIV-1) with enhanced dendritic cell and macrophage tropism comprising the simian immunodeficiency virus (SIV) minimal Vpx packaging domain

0

US Patent 9206479 Methods and compositions related to Staufen 1 binding sites formed by duplexing Alu elements

0

US Patent 9221908 Therapeutic CD47 antibodies

0

US Patent 9745368 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

0

US Patent 9845345 SIRP polypeptide compositions and methods of use

0

•••

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

0

Patent Primary Examiner

Janet L Epps-Smith

0

CPC Code

0

0

0

0

0

0

0

0

0

0

•••

Find more entities like US Patent 11672874 Methods and compositions for genomic integration

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.